Anika Therapeutics (NASDAQ:ANIK) announced its Q4 earnings on Thursday, February 26, 2026 at 07:05 AM.

Here's a breakdown of the earnings report.

Earnings

Anika Therapeutics beat estimated earnings by 616.67%, reporting an EPS of $0.31 versus an estimate of $-0.06.

Revenue was up $13 thousand from the same period last year.

Overview of Past Earnings

During the previous quarter, the company beat on EPS by $0.1, leading to a 1.02% drop share price change the next day.

Here's a look at Anika Therapeutics's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.06	-0.21	0.09	0.09
EPS Actual	0.04	-0.13	-0.06	-0.03
Revenue Estimate	27.80M	27.04M	28.07M	29.00M
Revenue Actual	27.80M	28.22M	26.20M	30.60M

To track all earnings releases for Anika Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.